Clinical Trials Using MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine

Clinical trials are research studies that involve people. The clinical trials on this list are studying MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Combined Vaccine Therapy in Treating Patients with Metastatic Solid Tumors

    This phase I trial studies the side effects and best dose of a combined vaccine therapy and to see how well it works in treating patients with solid tumors that have spread to other parts of the body (metastatic). The cancer vaccine is made up of two proteins (that look like the tumor cells) mixed up with a special compound that may help train and boost the immune system to recognize and fight the tumor cells.
    Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio